伊立替康
医学
间质性肺病
肺
内科学
风险因素
优势比
肺癌
胃肠病学
外科
癌症
结直肠癌
作者
Yuichi Ozawa,Keigo Koda,Daisuke Akahori,Takashi Matsui,Hirotsugu Hasegawa,Takuya Kakutani,TUSUKE AMANO,Masayuki Tanahashi,Hiroshi Niwa,Yukihiro Kunimoto,Kazunari Yamada,Koshi Yokomura,Takafumi Suda
出处
期刊:Anticancer Research
[International Institute of Anticancer Research (IIAR) Conferences 1997. Athens, Greece. Abstracts]
日期:2018-10-01
卷期号:38 (10): 5937-5941
被引量:11
标识
DOI:10.21873/anticanres.12939
摘要
The risk of lung injury with irinotecan was high when pre-ILD was present and the risk was comparable with previously reported other agents.
科研通智能强力驱动
Strongly Powered by AbleSci AI